General
Preferred name
SULFACYTINE
Synonyms
Sulfacitine ()
Renoquid ()
CI-636 ()
NSC-356717 ()
P&D ID
PD009917
CAS
1401-49-6
17784-12-2
Tags
available
drug
Approved by
FDA
First approval
1975
Drug Status
approved
withdrawn
Drug indication
Cystitis
Antibacterial
Urinary tract infection
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Sulfacytine, a benzenesulfonamide derivative, could be used as an antibiotic through restraining the formation of folate.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
13
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
MedChem Express Bioactive Compound Library
ReFrame library
Withdrawn 2.0
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
23
Molecular Weight
294.08
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
2
cLogP
0.65
TPSA
107.08
Fraction CSP3
0.17
Chiral centers
0.0
Largest ring
6.0
QED
0.8
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
ATC
G01AE10
Therapeutic Class
Antiinfective Agents
Pathway
Anti-infection
Target
antibiotic
Bacterial
Source data
